BACKGROUND Previous studies in the US and Canada, have shown the positive impact of early palliative care programs for advanced cancer patients on quality of life (QoL) and even survival time. There has been a lack of similar research in Europe. In order to generalize the findings from the US and Canada research on a larger scale, similar studies are needed in different countries with different...

Brain metastasis is common in patients with melanoma and represents a significant cause of morbidity and mortality. There have been no specific randomized trials for patients with melanoma brain metastasis, so treatment is based on management of brain metastasis in general and requires multidisciplinary expertise including radiation oncology, neurosurgery, medical oncology, and palliative care....

1 Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA 2 Department of Radiation Oncology, New York University Perlmutter Cancer Center, New York, NY, USA 3 Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA, USA 4 Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, MD, USA 5 Depar...

Materials and methods Data from the literature were revised, focusing our attention on published reviews on surgical and endoscopic palliation for oesophagus, colon-rectum and pancreatic-biliary cancers. We also obtained the data from the registries of our hospital on these very diagnoses. Finally, we requested the number of metallic stents sold in Italy and in Europe to one of the main manufac...

PURPOSE/OBJECTIVES To develop and test the Oncology Patients' Perceptions of the Quality of Nursing Care Scale (OPPQNCS). STUDY DESIGN Development and psychometric testing of a scale to measure perceptions of patients with cancer of quality of nursing care. SETTING AND SAMPLE Hematology-oncology service of a comprehensive center in a New England tertiary medical center. The sample consisted...

M. Dreyling1, M. Ghielmini2, R. Marcus3, G. Salles4, U. Vitolo5 & M. Ladetto6 on behalf of the ESMO Guidelines Working Group* Department of Medicine III, University of Munich, Munich, Germany; Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Haematology, Kings College Hospital, London, UK; Service D’Hématologie, Centre Hospitalier Lyon-Sud, Pierre-Beni...

From the 'Department of Microbiology, University of Geneva Medical School, Geneva, Switzerland; lImmunogenetics Research, The Blood Center ofSoutheastern Wisconsin, Milwaukee, Wisconsin; the SInstitutefor Immunology and Hematology-Oncology Unit, La Tour Hospital, Geneva, Switzerland; IIPuget Sound Blood Center and Fred Hutchinson Cancer Research Center, Seattle, Washington; AAmerican Red Cmss B...

198 CURRENT ONCOLOGY—VOLUME 15, NUMBER 4 Copyright © 2008 Multimed Inc. Educational service provided to physicians by an unrestricted grant from Sanofi-Aventis Introducing our new series of expert guest editorials reporting upon different aspects of practice. These are independently reviewed and supported by unrestricted educational grants from our colleagues in industry. I N V I T E D E D I T ...

DESCRIPTION This patient is a 76-year-old man with medical history of diabetes mellitus, hypertension, and multiple squamous cell skin cancers. Four years prior, he underwent dermatographic resection of a squamous cell carcinoma of the right cheek that had involved the right facial nerve. Two years later, the lesion recurred. Radical resection with control of free margins was performed by the h...